REBECCA RUNDBLAD: Open Payments
NPI 1316723745 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $150 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| GENZYME CORPORATION | 1 | $31 |
| Exact Sciences Corporation | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: RINVOQ, DUPIXENT, Cologuard Collection Kit, XIFAXAN, MOUNJARO, Wegovy, LINZESS, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
